discovery and development of biotherapeutic drugs using an automated, AI-assisted end-to-end platform and is developing next-generation biotherapeutic drug candidates
BioCopy has raised €18M across 2 funding rounds, most recently a Series A round in May 2026. Based in Basel, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-01 | Series A | €9.8M | — | View deal → |
| 2025-03-20 | Other | €8.0M | — | View deal → |
